Bruce Reinhold, PhD

Bruce Reinhold, PhD

Researcher

Contact Information

Office Phone Number

(617) 632-3121

Biography

Bruce Reinhold, PhD

Dr. Reinhold received his PhD in physics in 1992 from the University of Massachusetts at Amherst. He completed postgraduate training in biological mass spectrometry at Harvard School of Public Health, focusing on oligosaccharide and glycoconjugate analyses. In 2001, he joined the laboratory of Dr. Ellis Reinherz, applying mass spectrometry to immunology.

Researcher

Physician

Principal Associate in Medicine, Harvard Medical School

Research

    Molecular Detection Using Mass Spectrometry

    Biological fluids are enormously complex in molecular composition, and their analysis has become a central challenge in biology and medicine. Mass spectrometry (MS) is a method of analysis in which molecules are converted to gas phase ions and manipulated by electric and/or magnetic fields in a low pressure environment. We can measure the ion's mass-to-charge ratio, or isolate an ion of a given mass-to-charge ratio, induce it to fragment, and then measure the mass-to-charge ratio of the fragments, a process called MS/MS. Such measurements identify the molecule. Our laboratory has developed computer models and accumulated biomedical analyses data concerning a new type of ion optical device that has significant potential to address both research and clinical problems in biomarker development. The device would operate on a complex population of trapped ions to deduce structure from a hierarchy of ion selection and dissociation steps using multiple mass spectrometry (MSn). Mixtures would be analyzed without chromatographic separation using low-flow static electrospray (nanospray) giving optimal ionization efficiency (sensitivity), reducing costs, and simplifying operation. Technical properties of the ion selection physics allow for relatively low-amplitude radio frequency trapping fields and relatively low precision in electrode machining compared with existing MS instruments, thereby also reducing costs. The device would operate as a molecular detector in which a database of MSn fragmentation patterns would be used to quantify these molecular components in very complex biological samples at high sensitivity and at high dynamic range.

    Locations

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue HIM 422A Boston, MA 02215
    Get Directions

    Dana-Farber Cancer Institute

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue HIM 422A Boston, MA 02215
    Get Direction
    42.3374, -71.1082

    Discovery and Insights